ISO 13485 Certification: Boosting Quality and Compliance for Medical Device Manufacturers
Learn the steps to obtain ISO 13485 certification for medical device manufacturers. Understand the importance of a QMS in meeting regulatory standards and boosting competitive advantage. ISO 13485 is international standard which defines the requirements for a quality management system (QMS) in medical devices organization. The pursuit of an ISO 13485 certification is a critical […]
Internal Audits in Life Sciences: Ensuring Compliance & Quality Management
Learn how internal audits play a critical role in maintaining compliance and quality management in the life sciences industry. Discover key audit areas including GMP, GLP, and GCP. One critical necessity looms large throughout the myriad labyrinth of regulations which dictate the world of life sciences: Internal audits. Pharmaceuticals, biotech and medical devices are life […]
Understanding the FDA Drug Approval Process: Safety and Efficacy | BioBoston Consulting
Discover how the FDA ensures the safety and effectiveness of new drugs through a meticulous approval process. Learn about the steps involved and the experts behind drug approval. Each time we go to pick up a bottle of pills, we are putting an enormous amount of faith in the medical world, assuming whatever we are […]
Harmonizing Global Compliance for mRNA Immunotherapies | BioBoston Consulting
Discover how BioBoston Consulting helps navigate the complex regulatory landscape for mRNA immunotherapies. Learn about global compliance strategies and the importance of regulatory excellence. Adapted from an article first published by the world’s leading life science innovation knowledge hub. With mRNA Immunotherapies are breakthroughs in life science industry. With these types of new remedies on […]
Navigating FDA Regulations in Life Sciences | BioBoston Consulting
Stay updated on the evolving FDA regulatory landscape impacting the life sciences industry. Discover key influences on FDA regulations and strategies for navigating compliance. Stay informed about the recent regulatory changes that impact the life science industry. The US Food and Drug Administration (FDA) oversees this space, adjusting its rules as we struggle with newer […]
FDA Stability Testing Regulations for Pharmaceuticals | BioBoston Consulting
Explore the FDA’s stability testing regulations under Title 21, Part 211. Learn how stability studies ensure the safety, efficacy, and quality of pharmaceuticals throughout their shelf life. Introduction to Stability Testing Regulations demand robust usability of stability studies as an integral component of drug development and manufacturing process. Stability Studies are an essential instrument in […]
FDA Requirements for Reprocessing in Pharmaceutical Manufacturing | BioBoston Consulting
Learn about the FDA’s 21 CFR Part 211 requirements for reprocessing in pharmaceutical manufacturing. Discover the importance of quality control, written procedures, and corrective actions in ensuring product integrity. Quality standards and regulations that contribute to the safe, efficacious production of finished pharmaceuticals rely on a robust framework set forth in myriad guidelines and protocols. […]
FDA Requirements for Records and Reports in Drug Manufacturing | BioBoston Consulting
Discover the FDA’s requirements under 21 CFR Sec. 211.184 for maintaining records and reports in drug manufacturing. Learn about the importance of documentation for quality control, traceability, and regulatory compliance. The objective of 21 CFR Sec. 211.184 intends to follow in its second dual purpose of advocating for strong quality control systems and advancing the […]
FDA Draft Guidance for Cell and Gene Therapy Products: Enhancing Safety and Quality | BioBoston Consulting
Explore the FDA’s new draft guidance for cell and gene therapy (CGT) products. Learn key insights on risk evaluation, comparability studies, and the importance of quality management systems for successful manufacturing changes. In August 2020, the Food and Drug Administration (FDA) announced a draft guidance for industry titled Cellular & Gene Therapy. The guidance is […]
FDA Regulatory Submissions: Your Guide to Navigating Complexities | BioBoston Consulting
Navigating the Complexities of FDA IDE Submissions In the Medical device and Life sciences industries, obtaining Investigational Device Exemption (IDE) approval is a critical step for initiating clinical studies. Successful IDE applications require precise documentation, compliance with FDA regulations, and a clear regulatory strategy to reduce delays and ensure approval. BioBoston Consulting offers expert guidance to streamline IDE submissions, providing regulatory insights, risk-based strategies, and compliance […]